Understanding how the analysis of the market access and reimbursement team can impact the decision-making process or the structure or value of the deal
How does the market access assessment differ when working with early stage vs. late stage products?
Identifying the critical components that the BD team needs to know during the diligence process and uncovering any minefields that might be present
Incorporating a global market access view into the assessment
